How Does the Immune System Recognize Cancer Cells?
July 14, 2026Core Framework & Diagram How Do T Cells Kill Cancer Cells?
July 14, 2026
1 minuete Read
How Do T Cells Kill Cancer Cells?
When the immune system decides to kill a cancer cell, how exactly does a T cell do it?
By the Editors 1-min read
Inside your body right now, cells are being recognized as abnormal under T cell surveillance and eliminated — and you feel nothing at all.
CD8+ T cells are the executors of this process. They first recognize abnormal protein fragments displayed on the cancer cell's surface, confirm the target, then make tight contact with the cancer cell and inject a toxic protein directly inside — causing the cancer cell to collapse and die from within.
The entire process resembles precision surgery: the goal is to eliminate cancer cells at a specific point without harming surrounding normal cells. This precision is T cells' most remarkable property — something no chemotherapy drug can match.
KEY TAKEAWAYS
01
CD8+ T cell precision killing: TCR recognizes MHC-I/neoantigen confirming target cell; immunological synapse forms for directed toxin delivery; kills only cancer cells expressing the specific neoantigen, doesn't harm surrounding normal cells — precision far exceeding chemotherapy.
02
The immunological synapse is a highly ordered killing interface: ensures perforin and granzyme B are directionally 'injected' into the target cell, not dispersed into surroundings — achieving precision 'point demolition' without harming bystanders.
03
Perforin punctures membrane → granzyme B enters → activates caspase-3 → orderly target cell apoptosis (not necrosis, triggers no additional inflammation) — the primary molecular mechanism of cancer killing, clean and orderly, leaving no 'wreckage.'
04
CAR-T cells: equips T cells with an MHC-I-independent artificial navigation system that can recognize and kill any tumor cell expressing a specific target antigen — achieved breakthroughs in blood cancers; this is a revolution in cellular immunotherapy.
05
T cell exhaustion is a key tumor immune evasion mechanism: sustained tumor pressure plus inhibitory signals cause T cells to go from soldiers to exhausted fighters. PD-1 inhibitors' value is helping T cells recover from fatigue — not making them 'stronger.'
Read Next
